A series
of rare-earth (RE) metal complexes (Y, Sm, Nd, and La)
stabilized by polydentate N-methylethylenediamine-bridged
tris(phenolato) ligands was synthesized and characterized. Lanthanum
complexes showed good activity in catalyzing the cycloaddition reaction
of terminal epoxides with CO2 under ambient conditions
(i.e., room temperature, 1 bar CO2), giving rise to cyclic
carbonates in 49–99% yields. More importantly, generally challenging
internal epoxides were also transformed into cyclic carbonates in
70–99% yields in the presence of 1 bar CO2 at 60
°C. This is the first RE-based catalyst for efficient cycloaddition
of CO2 and epoxides under ambient conditions and is among
the most active catalysts for this important transformation. The lanthanum
complex was also recycled six times. Kinetic study of the cycloaddition
of cyclohexene oxide and CO2 was conducted, and the kinetic
equation was determined as follows: rate = k[epoxide]1[CO2]0[cat.]1.26[TBAI]0.4. The Gibbs activation energy (333 K) was determined to
be 29.8 kcal/mol.
Accumulated evidence demonstrates that Japanese encephalitis virus (JEV) infection triggers endoplasmic reticulum (ER) stress and neuron apoptosis. ER stress sensor protein kinase R-like endoplasmic reticulum kinase (PERK) has been reported to induce apoptosis under acute or prolonged ER stress. However, the precise role of PERK in JEV-induced apoptosis and encephalitis remains unknown. Here, we report that JEV infection activates the PERK-ATF4-CHOP apoptosis pathway both in vitro and in vivo. PERK activation also promotes the formation of stress granule, which in turn represses JEV-induced apoptosis. However, PERK inhibitor reduces apoptosis, indicating that JEV-activated PERK predominantly induces apoptosis via the PERK-ATF4-CHOP apoptosis pathway. Among JEV proteins that have been reported to induce ER stress, only JEV NS4B can induce PERK activation. PERK has been reported to form an active molecule by dimerization. The coimmunoprecipitation assay shows that NS4B interacts with PERK. Moreover, glycerol gradient centrifugation shows that NS4B induces PERK dimerization. Both the LIG-FHA and the LIG-WD40 domains within NS4B are required to induce PERK dimerization, suggesting that JEV NS4B pulls two PERK molecules together by simultaneously interacting with them via different motifs. PERK deactivation reduces brain cell damage and encephalitis during JEV infection. Furthermore, expression of JEV NS4B is sufficient to induce encephalitis via PERK in mice, indicating that JEV activates PERK primarily via its NS4B to cause encephalitis. Taken together, our findings provide a novel insight into JEV-caused encephalitis.
IMPORTANCE Japanese encephalitis virus (JEV) infection triggers endoplasmic reticulum (ER) stress and neuron apoptosis. ER stress sensor protein kinase R-like endoplasmic reticulum kinase (PERK) has been reported to induce apoptosis under acute or prolonged ER stress. However, whether the PERK pathway of ER stress response plays important roles in JEV-induced apoptosis and encephalitis remains unknown. Here, we found that JEV infection activates ER stress sensor PERK in neuronal cells and mouse brains. PERK activation induces apoptosis via the PERK-ATF4-CHOP apoptosis pathway upon JEV infection. Among the JEV proteins prM, E, NS1, NS2A, NS2B, and NS4B, only NS4B activates PERK. Moreover, activated PERK participates in apoptosis and encephalitis induced by JEV and NS4B. These findings provide a novel therapeutic approach for JEV-caused encephalitis.
An efficient protocol for the selective synthesis of α-mono or α,α′-dihalo ketones via a water-controlled chemodivergent and regiospecific cascade reaction has been developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.